Disseminated cutaneous and visceral fusariosis in an aplastic patient: An unusual digestive entry;Fusariose cutanée et viscérale disséminée chez un malade en aplasie: Une porte d'entrée digestive inhabituelle

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 3, 2005, Pages 255-258

  Karam, A ^a,b   Eveillard, J R ^a   Ianoto, J C ^a   Quinio, D ^a   Le Flohic, A M ^a   Le Roy, J P ^a   Misery, L ^a   Berthou, C ^a  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; CYTARABINE; VORICONAZOLE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANTIFUNGAL ACTIVITY; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CONTAMINATION; DIGESTIVE FUNCTION; FUSARIUM MONILIFORME; HUMAN; HYPHOMYCETES; MALE; MICROBIOLOGICAL EXAMINATION; MOULD; OPPORTUNISTIC INFECTION; SKIN BIOPSY; SKIN DISEASE;

EID: 17444367020     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79257-7     Document Type: Article

References (11)

1. Nelson PE, Dignani MC, Anaissie EJ. Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 1994;7:479-504.
2. Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002;35:909-20.
3. Pereiro M, Abalde MT, Zulaica A, Caeiro C, Florez A, Peteiro C et al. Chronic infection due to Fusarium oxysporum mimicking lupus vulgaris: case report and review of cutaneous involvement in fusariosis. Acta Derm Venereol 2001;81:51-3.
4. Hay RJ, Mackenzie DW. Mycetoma (Madura foot) in the United Kingdom - a survey of forty four cases. Clin Exp Dermatol 1983;8:553-62.
5. Lavarde V, Henneauin C. Infections à fusarium, Encycl Med Chir (Elsevier, Paris), Maladies infectieuses, 8-580-A-10:page 3.
6. Letscher-Bru V, Campos F, Waller, Randrimahazak R, Candolfi E, Herbrecht R. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J Clin Microbiol 2002;40:1100-2.
7. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 1997;90:999-1008.
8. Hennequin, C, Lavarde V, Poirot JL, Rambodonirina M, Datry A, Aractingi S et al. Invasive Fusarium infections: a retrospective survey of 31 cases. The French 'Groupe d'Etudes des Mycoses Opportunistes' GEMO. J Med Vet Mycol 1997;35:107-14.
9. Martino P, Gastaldi R, Raccah R, Germenia C, Rambodonirina M, Datry A et al. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;28Suppl1:7-15.
10. Rabodonirina M, Piens MA, Monier MF, Gueho D, Fiere D, Majon M. Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis 1994;13:152-61.
11. Perfect JR, Marr KA, Walsh TJ, Greenberg RN, Dupont B, De la Torre-Cisneros J et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003;36:1122-31.